MedTrace Logo

Endocan Level in Patients With Erectile Dysfunction and Relationship With Tadalafil Treatment

NCT05109377 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 90

Last updated 2021-11-05

No results posted yet for this study

Summary

The investigators analyze the patients' endocan levels, IIEF scores, and hormon levels both before and after tadalafil (5 or 20mg) treatment. The investigators want to see erectile dysfunction severity and tadalafil treatment relations with endocen level.

Conditions

Interventions

DIAGNOSTIC_TEST

Endocan

Endocan will measured before and after treatment

DRUG

tadalafil

tadalafil

Sponsors & Collaborators

  • Ankara Training and Research Hospital

    lead OTHER

Principal Investigators

  • Veysel Bayburtluoğlu · Ministry of Health

Study Design

Allocation
RANDOMIZED
Purpose
DIAGNOSTIC
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-06-24
Primary Completion
2021-11-15
Completion
2021-12-15

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05109377 on ClinicalTrials.gov